Company Filing History:
6 out of 109 
5 out of 3,224 
Years Active: 2015-2021
Title: Innovations and Contributions of Shannon Marie Decker
Introduction
Shannon Marie Decker is a prominent inventor based in Burnaby, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target voltage-gated sodium channels. With a total of 6 patents to her name, her work has the potential to impact the treatment of various neurological disorders.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Benzenesulfonamide Compounds and Their Use as Therapeutic Agents." This invention focuses on benzenesulfonamide compounds, including their stereoisomers, enantiomers, and tautomers, as well as their pharmaceutically acceptable salts and prodrugs. These compounds are designed for the treatment of diseases associated with voltage-gated sodium channels, such as epilepsy and epileptic seizure disorders. Another notable patent is for "Substituted Benzamides Useful as Sodium Channel Blockers." This invention provides compounds with a specific general formula and outlines their potential applications in medical treatments.
Career Highlights
Shannon has worked with notable companies in the pharmaceutical industry, including Xenon Pharmaceuticals Inc. and Genentech, Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical science.
Collaborations
Throughout her career, Shannon has collaborated with esteemed colleagues, including Sultan Chowdhury and Christoph Martin Dehnhardt. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic agents.
Conclusion
Shannon Marie Decker's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in the treatment of neurological disorders.